Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

ARMP holding history

Armata Pharmaceuticals, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARMP overviewAll 13F holders of ARMPFull Q4 2025 holdings

Shares (Q4 2025)
357,649
Value
$2.25M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ARMP by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 2025357,649$2.25M<0.1%+60,611+20.4%AddedHolders
Q3 2025297,038$885.2K<0.1%+36,965+14.2%AddedHolders
Q2 2025260,073$494.1K<0.1%00.0%UnchangedHolders
Q1 2025260,073$379.7K<0.1%+25,954+11.1%AddedHolders
Q4 2024234,119$433.1K<0.1%+8,832+3.9%AddedHolders
Q3 2024225,287$533.9K<0.1%+19,534+9.5%AddedHolders
Q2 2024205,753$565.8K<0.1%+46,544+29.2%AddedHolders
Q1 2024159,209$665.5K<0.1%+14,131+9.7%AddedHolders
Q4 2023145,078$470.1K<0.1%+54,109+59.5%AddedHolders
Q3 202390,969$272.9K<0.1%+31,079+51.9%AddedHolders
Q2 202359,890$68.3K<0.1%+2,708+4.7%AddedHolders
Q1 202357,182$95.5K<0.1%+13,387+30.6%AddedHolders
Q4 202243,795$54.3K<0.1%−243,555−84.8%ReducedHolders
Q3 2022287,350$1.21M<0.1%+14,200+5.2%AddedHolders
Q2 2022273,150$1.06M<0.1%00.0%UnchangedHolders
Q1 2022273,150$1.33M<0.1%+10,400+4.0%AddedHolders
Q4 2021262,750$1.44M<0.1%+94,092+55.8%AddedHolders
Q3 2021168,658$610.0K<0.1%+1,280+0.8%AddedHolders
Q2 2021167,378$665.0K<0.1%+91,782+121.4%AddedHolders
Q1 202175,596$362.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.